MIR2392 (microRNA 2392)

2017-10-01  

Identity

HGNC
MIR2392
LOCATION
14q32.2
LOCUSID
100616495
ALIAS
-

Other Information

Locus ID:

NCBI: 100616495
HGNC: 41843
Ensembl: ENSG00000266461
miRBase:

Variants:

dbSNP: 100616495
ClinVar: 100616495
TCGA: ENSG00000266461
COSMIC: MIR2392

RNA/Proteins

References

Pubmed IDYearTitleCitations
373930602023Positive effect of miR-2392 on fibroblast to cardiomyocyte-like cell fate transition: An in silico and in vitro study.1
373930602023Positive effect of miR-2392 on fibroblast to cardiomyocyte-like cell fate transition: An in silico and in vitro study.1
354853552022miR-2392 functions as tumour suppressor and inhibits malignant progression of hepatocellular carcinoma via directly targeting JAG2.5
354853552022miR-2392 functions as tumour suppressor and inhibits malignant progression of hepatocellular carcinoma via directly targeting JAG2.5
346242082021Role of miR-2392 in driving SARS-CoV-2 infection.33
346242082021Role of miR-2392 in driving SARS-CoV-2 infection.33
309086342019LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway.16
316524452019BTXA regulates the epithelial-mesenchymal transition and autophagy of keloid fibroblasts via modulating miR-1587/miR-2392 targeted ZEB2.4
309086342019LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway.16
316524452019BTXA regulates the epithelial-mesenchymal transition and autophagy of keloid fibroblasts via modulating miR-1587/miR-2392 targeted ZEB2.4
285121912017MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer.16
285121912017MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer.16

Citation

Dessen P

MIR2392 (microRNA 2392)

Atlas Genet Cytogenet Oncol Haematol. 2017-10-01

Online version: http://atlasgeneticsoncology.org/gene/57219/js/lib/deep-insight-explorer/